Evaluation of [

Alzheimer’s disease Tau imaging corticobasal degeneration progressive supranuclear palsy tauopathy

Journal

Brain communications
ISSN: 2632-1297
Titre abrégé: Brain Commun
Pays: England
ID NLM: 101755125

Informations de publication

Date de publication:
2021
Historique:
accepted: 28 06 2021
entrez: 11 10 2021
pubmed: 12 10 2021
medline: 12 10 2021
Statut: epublish

Résumé

Tau aggregates represent a key pathologic feature of Alzheimer's disease and other neurodegenerative diseases. Recently, PET probes have been developed for

Identifiants

pubmed: 34632382
doi: 10.1093/braincomms/fcab190
pii: fcab190
pmc: PMC8495135
doi:

Types de publication

Journal Article

Langues

eng

Pagination

fcab190

Informations de copyright

© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain.

Références

Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
J Nucl Med. 2020 Jun;61(6):911-919
pubmed: 31712323
Front Aging Neurosci. 2018 Jan 17;9:440
pubmed: 29387005
Brain. 2017 Mar 1;140(3):764-780
pubmed: 28087578
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1686-99
pubmed: 26996778
Neurol Sci. 2021 Aug;42(8):3471-3474
pubmed: 33945032
Mov Disord. 2021 Sep;36(9):2104-2115
pubmed: 33951244
Neurology. 2013 Jan 29;80(5):496-503
pubmed: 23359374
Brain. 2020 Dec 5;143(11):3477-3494
pubmed: 33141172
Acta Neuropathol Commun. 2016 Jun 13;4(1):58
pubmed: 27296779
Ann Neurol. 2015 Nov;78(5):787-800
pubmed: 26344059
Neuropathology. 2006 Oct;26(5):475-83
pubmed: 17080728
J Neuropathol Exp Neurol. 2002 Nov;61(11):935-46
pubmed: 12430710
Neuroimage. 2015 Jun;113:184-95
pubmed: 25776214
Prog Neurobiol. 2019 Sep;180:101644
pubmed: 31238088
JAMA Neurol. 2020 Aug 1;77(8):955-965
pubmed: 32391858
Ann Neurol. 2017 Jan;81(1):117-128
pubmed: 27997036
Brain Nerve. 2012 Apr;64(4):462-73
pubmed: 22481519
Brain. 2007 Jun;130(Pt 6):1552-65
pubmed: 17405767
Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2178-2189
pubmed: 31264169
JAMA Neurol. 2020 Nov 1;77(11):1408-1419
pubmed: 33165511
Neurology. 1997 Apr;48(4):959-69
pubmed: 9109885
Alzheimers Dement. 2020 Mar;16(3):561-571
pubmed: 31784374
Neuron. 2013 Sep 18;79(6):1094-108
pubmed: 24050400
Brain. 2019 Oct 1;142(10):3265-3279
pubmed: 31504227
Ann Neurol. 2020 Nov;88(5):1009-1022
pubmed: 32869362
Mov Disord. 2008 Nov 15;23(15):2129-70
pubmed: 19025984
Ann Neurol. 2017 Oct;82(4):622-634
pubmed: 28980714
Am J Pathol. 2002 Jun;160(6):2045-53
pubmed: 12057909
Acta Neuropathol Commun. 2017 Oct 19;5(1):75
pubmed: 29047416
J Neurol Sci. 2021 Jun 15;425:117440
pubmed: 33866113
Acta Neuropathol. 1999 Oct;98(4):341-4
pubmed: 10502037
Ann Neurol. 2004 Jan;55(1):72-9
pubmed: 14705114
Am J Psychiatry. 1984 Nov;141(11):1356-64
pubmed: 6496779
Brain. 2017 Mar 1;140(3):781-791
pubmed: 28122879
Eur Neurol. 2017;77(5-6):231-237
pubmed: 28285306
J Clin Psychol. 1998 Aug;54(5):585-91
pubmed: 9696108
Acta Neuropathol. 1971;19(4):347-52
pubmed: 5143983
J Nucl Med. 2018 Jan;59(1):117-120
pubmed: 28775201
Eur J Neurol. 2017 Jan;24(1):130-136
pubmed: 27797445
J Nucl Med. 2016 Jun;57(6):900-6
pubmed: 26823561
Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2233-2244
pubmed: 32572562
Mov Disord. 2019 May;34(5):744-754
pubmed: 30892739
J Nucl Med. 2019 Jan;60(1):107-114
pubmed: 29880509
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Neurology. 2017 Aug 22;89(8):845-853
pubmed: 28754841
Neurology. 2016 Nov 29;87(22):2309-2316
pubmed: 27794115
Neuron. 2021 Jan 6;109(1):42-58.e8
pubmed: 33125873
Ann Neurol. 2004 Mar;55(3):306-19
pubmed: 14991808
Acta Neuropathol. 2020 Aug;140(2):99-119
pubmed: 32383020
J Neurol. 1999 Sep;246 Suppl 2:II6-15
pubmed: 10525997

Auteurs

Toshiki Tezuka (T)

Department of Neurology, Keio University School of Medicine, Tokyo, Japan.

Keisuke Takahata (K)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.

Morinobu Seki (M)

Department of Neurology, Keio University School of Medicine, Tokyo, Japan.

Hajime Tabuchi (H)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Yuki Momota (Y)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Mika Shiraiwa (M)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Natsumi Suzuki (N)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Ayaka Morimoto (A)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Tadaki Nakahara (T)

Department of Diagnostic Radiology, Keio University School of Medicine, Tokyo 160-8582, Japan.

Yu Iwabuchi (Y)

Department of Diagnostic Radiology, Keio University School of Medicine, Tokyo 160-8582, Japan.

Eisuke Miura (E)

Department of Pathology, Keio University School of Medicine, Tokyo 160-8582, Japan.

Yasuharu Yamamoto (Y)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Yasunori Sano (Y)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Kei Funaki (K)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Bun Yamagata (B)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Ryo Ueda (R)

Office of Radiation Technology, Keio University Hospital, Tokyo 160-8582, Japan.

Takahito Yoshizaki (T)

Department of Neurology, Keio University School of Medicine, Tokyo, Japan.

Kyoko Mashima (K)

Department of Neurology, Tokyo Saiseikai Central Hospital, Tokyo 108-0073, Japan.

Mamoru Shibata (M)

Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
Department of Neurology, Tokyo Dental College Ichikawa General Hospital, Tokyo 272-8513, Japan.

Munenori Oyama (M)

Department of Neurology, Keio University School of Medicine, Tokyo, Japan.

Kensuke Okada (K)

Department of Neurology, Keio University School of Medicine, Tokyo, Japan.

Masahito Kubota (M)

Department of Neurology, Keio University School of Medicine, Tokyo, Japan.

Hajime Okita (H)

Department of Pathology, Keio University School of Medicine, Tokyo 160-8582, Japan.

Masaki Takao (M)

Department of Clinical Laboratory, National Center of Neurology and Psychiatry (NCNP), National Center Hospital, Tokyo 187-8551, Japan.
Brain Bank, Mihara Memorial Hospital, Gunma 372-0006, Japan.

Masahiro Jinzaki (M)

Department of Diagnostic Radiology, Keio University School of Medicine, Tokyo 160-8582, Japan.

Jin Nakahara (J)

Department of Neurology, Keio University School of Medicine, Tokyo, Japan.

Masaru Mimura (M)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Daisuke Ito (D)

Department of Neurology, Keio University School of Medicine, Tokyo, Japan.

Classifications MeSH